HomeCompareENMHF vs PFE

ENMHF vs PFE: Dividend Comparison 2026

ENMHF yields 5000.00% · PFE yields 6.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ENMHF wins by $62217131802825.30M in total portfolio value
10 years
ENMHF
ENMHF
● Live price
5000.00%
Share price
$0.04
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$62217131802825.35M
Annual income
$59,861,980,287,378,210,000.00
Full ENMHF calculator →
PFE
Pfizer Inc.
● Live price
6.13%
Share price
$28.08
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$26,258.71
Full PFE calculator →

Portfolio growth — ENMHF vs PFE

📍 ENMHF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodENMHFPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ENMHF + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ENMHF pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ENMHF
Annual income on $10K today (after 15% tax)
$425,000.00/yr
After 10yr DRIP, annual income (after tax)
$50,882,683,244,271,480,000.00/yr
PFE
Annual income on $10K today (after 15% tax)
$520.66/yr
After 10yr DRIP, annual income (after tax)
$22,319.90/yr
At 15% tax rate, ENMHF beats the other by $50,882,683,244,271,450,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ENMHF + PFE for your $10,000?

ENMHF: 50%PFE: 50%
100% PFE50/50100% ENMHF
Portfolio after 10yr
$31108565901412.70M
Annual income
$29,930,990,143,689,118,000.00/yr
Blended yield
96.21%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

ENMHF
No analyst data
Altman Z
29.8
Piotroski
5/9
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-2.1% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ENMHF buys
0
PFE buys
0
No recent congressional trades found for ENMHF or PFE in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricENMHFPFE
Forward yield5000.00%6.13%
Annual dividend / share$2.00$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%13.2%
Portfolio after 10y$62217131802825.35M$49.6K
Annual income after 10y$59,861,980,287,378,210,000.00$26,258.71
Total dividends collected$62057786341622.61M$58.3K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: ENMHF vs PFE ($10,000, DRIP)

YearENMHF PortfolioENMHF Income/yrPFE PortfolioPFE Income/yrGap
1← crossover$510,700$500,000.00$9,153$693.39+$501.5KENMHF
2$24,410,935$23,864,485.98$8,593$849.25+$24.40MENMHF
3$1,092,192,501$1,066,072,800.30$8,336$1,066.78+$1092.18MENMHF
4$45,746,366,951$44,577,720,975.17$8,437$1,384.80+$45746.36MENMHF
5$1,793,932,828,410$1,744,984,215,772.56$9,013$1,875.40+$1793932.82MENMHF
6$65,871,973,805,320$63,952,465,678,921.49$10,306$2,680.72+$65871973.80MENMHF
7$2,265,146,887,602,700$2,194,663,875,631,007.20$12,820$4,101.38+$2265146887.59MENMHF
8$72,954,689,148,998,180$70,530,981,979,263,280.00$17,673$6,826.70+$72954689148.98MENMHF
9$2,201,076,182,660,884,700$2,123,014,665,271,456,500.00$27,543$12,591.86+$2201076182660.86MENMHF
10$62,217,131,802,825,350,000$59,861,980,287,378,210,000.00$49,560$26,258.71+$62217131802825.30MENMHF

ENMHF vs PFE: Complete Analysis 2026

ENMHFStock

ENM Holdings Limited, an investment holding company, engages in the retail of fashion wear and accessories. It operates through three segments: Retail of Fashion Wear and Accessories; Resort and Recreational Club Operations; and Investments. The company operates a chain of multi-label stores, as well as mono-brand boutiques under The Swank brand in Hong Kong and China; and Hilltop Country Club that provides conferences, dining, lodging, recreational, and outdoor activities for its members in Hong Kong, as well as offers menswear fashion products under the Cesare di Pino brand name. It also holds and trades in investments for short term and long term investment returns. The company was formerly known as e-New Media Company Limited and changed its name to ENM Holdings Limited in June 2005. ENM Holdings Limited was incorporated in 1966 and is based in Tsuen Wan, Hong Kong.

Full ENMHF Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this ENMHF vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ENMHF vs SCHDENMHF vs JEPIENMHF vs OENMHF vs KOENMHF vs MAINENMHF vs JNJENMHF vs MRKENMHF vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.